Zevra Therapeutics Preferred Securities out of Shareholders Equity (Quarterly) Analysis

Zevra Therapeutics, Inc. (ZVRA)

8.93 -0.09 (-1.00%) USD | NASDAQ | Jan 16, 16:00

9.10 +0.17 (+1.90%) After-Hours: 20:00

View Preferred Securities out of Shareholders Equity (Quarterly) for ZVRA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Preferred Securities out of Shareholders Equity (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Preferred Securities out of Shareholders Equity (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Preferred Securities out of Shareholders Equity (Quarterly) Benchmarks

Start Trial

XOMA Royalty Corp.	--
Verastem, Inc.	Upgrade
ADMA Biologics, Inc.	--
Akebia Therapeutics, Inc.	--
NovaBay Pharmaceuticals, Inc.	--